XML 64 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Long-Term Investments (Details) - Schedule of balance sheet - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
BioFirst [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets $ 1,543,151 $ 2,205,669
Noncurrent Assets 739,472 959,454
Current Liabilities 2,663,051 2,909,703
Noncurrent Liabilities 103,447 32,522
Stockholders’ Equity (Deficit) 483,874 222,898
Rgene [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets 68,302 73,452
Noncurrent Assets 303,893 374,423
Current Liabilities 2,478,868 1,934,786
Noncurrent Liabilities 2,441
Stockholders’ Equity (Deficit) $ (2,481,309) $ (1,486,911)